Induction of General Anesthesia Dogs: 1-2 mg/lb (2.2-4.4 mg/kg), intravenously
Diagnostic purposes: Dogs: 3 to 4.5 mg/lb (6.6 to 9.9 mg/kg) intramuscularly Cats: 4.4 to 5.4 mg/lb (9.7 to 11.9 mg/kg) intramuscularly
Minor procedures: Dogs: 4.5 to 6 mg/lb (9.9 to 13.2 mg/kg) intramuscularly Cats: 4.8 to 5.7 mg/lb (10.6 to 12.5 mg/kg) intramuscularly
IMPORTANT SAFETY INFORMATION:
Do not use TELAZOL in dogs and cats with pancreatic disease or severe cardiac or pulmonary dysfunction. Do not use for Caesarean section. Safe use in pregnant dogs or cats has not been established. Use in cats with renal dysfunction is not recommended; pre-existing renal disease may prolong duration of anesthesia. When used for induction of anesthesia, patients should be continuously monitored. Do not use phenothiazine derivative drugs concomitantly with TELAZOL when given at the IM dosages, as the combination produces respiratory and myocardial depression, hypotension, and hypothermia. Pulmonary edema has been reported in cats. Respiratory depression may occur following administration of high doses of TELAZOL. Post-induction apnea may occur when Telazol is administered IV as an induction agent. Common adverse events included hypotension, hypothermia, elevated body temperature and decreased SPO2; frequency varied based on the type of premedication used. See full Prescribing Information.